Last reviewed · How we verify

IncobotulinumtoxinA 100 UNT Injection [Xeomin]

University Of Perugia · Phase 3 active Small molecule

IncobotulinumtoxinA 100 UNT Injection [Xeomin] is a Botulinum toxin Small molecule drug developed by University Of Perugia. It is currently in Phase 3 development for Cervical dystonia, Blepharospasm, Hemifacial spasm. Also known as: Incobot/A.

IncobotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

IncobotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Hemifacial spasm.

At a glance

Generic nameIncobotulinumtoxinA 100 UNT Injection [Xeomin]
Also known asIncobot/A
SponsorUniversity Of Perugia
Drug classBotulinum toxin
TargetSNAP-25 (synaptosome-associated protein of 25 kDa)
ModalitySmall molecule
Therapeutic areaNeurology, Dermatology, Aesthetics
PhasePhase 3

Mechanism of action

IncobotulinumtoxinA is a botulinum toxin serotype A that irreversibly cleaves SNAP-25, a protein essential for acetylcholine vesicle fusion and release. This prevents neuromuscular transmission, resulting in localized muscle weakness or paralysis. The effect is temporary, typically lasting 3-4 months, after which neuromuscular function gradually recovers.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about IncobotulinumtoxinA 100 UNT Injection [Xeomin]

What is IncobotulinumtoxinA 100 UNT Injection [Xeomin]?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] is a Botulinum toxin drug developed by University Of Perugia, indicated for Cervical dystonia, Blepharospasm, Hemifacial spasm.

How does IncobotulinumtoxinA 100 UNT Injection [Xeomin] work?

IncobotulinumtoxinA blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

What is IncobotulinumtoxinA 100 UNT Injection [Xeomin] used for?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] is indicated for Cervical dystonia, Blepharospasm, Hemifacial spasm, Glabellar lines (wrinkles), Spasticity.

Who makes IncobotulinumtoxinA 100 UNT Injection [Xeomin]?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] is developed by University Of Perugia (see full University Of Perugia pipeline at /company/university-of-perugia).

Is IncobotulinumtoxinA 100 UNT Injection [Xeomin] also known as anything else?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] is also known as Incobot/A.

What drug class is IncobotulinumtoxinA 100 UNT Injection [Xeomin] in?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] belongs to the Botulinum toxin class. See all Botulinum toxin drugs at /class/botulinum-toxin.

What development phase is IncobotulinumtoxinA 100 UNT Injection [Xeomin] in?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] is in Phase 3.

What are the side effects of IncobotulinumtoxinA 100 UNT Injection [Xeomin]?

Common side effects of IncobotulinumtoxinA 100 UNT Injection [Xeomin] include Injection site pain or bruising, Headache, Muscle weakness or paralysis (off-target), Ptosis (eyelid drooping), Dry mouth, Neck pain.

What does IncobotulinumtoxinA 100 UNT Injection [Xeomin] target?

IncobotulinumtoxinA 100 UNT Injection [Xeomin] targets SNAP-25 (synaptosome-associated protein of 25 kDa) and is a Botulinum toxin.

Related